Bradley A Katz

Title: The Innovations of Bradley A Katz

Introduction

Bradley A Katz is a notable inventor based in San Francisco, CA, with a significant contribution to the field of serine protease inhibitors. He holds a total of six patents, showcasing his innovative approach to biochemical research and development.

Latest Patents

One of his latest patents is titled "Metal mediated serine protease inhibitors." This invention relates to serine protease inhibitors that possess a P site binding moiety and a divalent cation(s) chelating moiety. These inhibitors can be pre-prepared as divalent cation(s) complexes or combined with the serine protease in the presence of divalent cation(s). The methods for identifying and using these inhibitors demonstrate high inhibitory activity when complexed to divalent cation(s), making them useful in various processes associated with serine protease isolation and inhibition. Another significant patent is "Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions." This patent presents a method for determining if the inhibition of metal mediated serine proteases can be enhanced by cobalt or zinc ions.

Career Highlights

Throughout his career, Bradley A Katz has worked with prominent organizations, including Axys Pharmaceuticals, Inc. and the University of California. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Bradley has collaborated with notable individuals in his field, including James M Clark and Thomas E Jenkins. These collaborations have likely enriched his research and led to further innovations in his area of expertise.

Conclusion

Bradley A Katz's contributions to the field of serine protease inhibitors highlight his innovative spirit and dedication to scientific advancement. His patents reflect a deep understanding of biochemical processes and a commitment to developing effective solutions.